723 resultados para feline herpesvirus
Resumo:
Dissertação de Mestrado Integrado em Medicina Veterinária
Resumo:
Background: Langerhans cell histiocytosis is a rare proliferative histiocytic disease of unknown etiology. Histologically, it is characterized by granuloma-like proliferation of Langerhans-type dendritic cells derived from bone marrow. Many investigators have suggested the possible role of viruses such as Epstein-Barr virus, human herpesvirus-6 (HHV-6), herpes simplex virus (HSV) types 1 and 2, and Cytomegalovirus in the pathogenesis of Langerhans cell histiocytosis. Objectives: In this study, we have investigated the presence of Cytomegalovirus in Langerhans cell histiocytosis in Iranian children. Patients and Methods: In this retrospective study, we have investigated the presence of Cytomegalovirus DNA expression, using paraffin-embedded tissue samples of 30 patients with Langerhans cell histiocytosis and 30 age and site-matched controls by qualitative Polymerase Chain Reaction (PCR) method. Results: No significant difference in prevalence of Cytomegalovirus presence between patients and controls was found. Cytomegalovirus was found by qualitative PCR in only 2 (6.66%) out of 30 patients and in 1 (3.3%) of 30 control samples with a P value of 1 (1.00 > 0.05) using chi-square test with OR: 2.07; 95% CI of OR: 0.18 - 24.15. Conclusions: Our findings do not support the hypothesis of a possible role for Cytomegalovirus in the pathogenesis of Langerhans cell histiocytosis.
Resumo:
Le rôle de l'inflammation dans le développement et la progression des maladies rénales chroniques (MRC) chez le chat a été peu étudié. L'hepcidine est une protéine de la phase aigue (PPA) de l'inflammation qui contribue au développement des anémies lors de MRC chez l'homme. Les objectifs de cette étude sont de comparer les concentrations en PPAs, en erythropoietine (EPO) ainsi que le statut en fer entre un groupe de chats sains et en MRC. 18 chats sains et 38 chats en MRC ont été recrutés de façon prospective. Les examens réalisés incluaient hématologie, biochimie, analyse d'urine, Serum amyloid A (SAA), haptoglobine (HAP), EPO, hepcidine,fer, TIBC et ferritinne. Nous avons observé une augmentation significative des concentrations en SAA et en hepcidine ainsi qu'une diminution significative du fer et du TIBC dans le groupe MRC (P < .05). Une corrélation positive entre la créatinine et certaines PPAs (SAA and hepcidin; P < .05) était présente. L'augmentation de SAA et hepcidine était significativement associé avec une diminution du TIBC et de l'hématocrite dans le groupe MRC. Les 14 (37%) chats anémiques du groupe MRC avaient une concentration significativement plus basse en fer et en TIBC (P < .05), changements compatibles avec une déficience fonctionelle en fer. Aucun chat n'avait un panel de fer compatible avec une carence en fer absolue. En conclusion, les résultats de cette étude suggèrent que les MRC chez le chat sont des conditions pro-inflammatoires, ayant un impact sur le métabolisme du fer.
Resumo:
Introduction : Malgré leur état non-prolifératif in vivo, les cellules endothéliales cornéennes (CEC) peuvent être amplifiées in vitro. Leur transplantation subséquente par injection intracamérale pourrait surmonter la pénurie de tissus associée à l’allo-greffe traditionnelle – l’unique traitement définitif disponible pour les endothéliopathies cornéennes. Objectif : Évaluer la fonctionnalité d’un endothélium cornéen reconstitué par injection de CEC dans la chambre antérieure du félin. Méthodes : Les yeux droits de 16 animaux ont été opérés. Huit ont été désendothélialisés centralement avec injection de 2x10e5 (n=4) ou 1x10e6 (n=4) CEC félines supplémentées avec Y-27632 et marquées avec SP-DiOC18(3). Deux ont été désendothélialisés complètement et injectés avec 1x10e6 CEC et Y-27632. Six contrôles ont été désendothélialisés centralement (n=3) ou complètement (n=3) et injectés avec Y-27632 sans CEC. La performance clinique, l’intégrité anatomique, le phénotype fonctionnel et l’expression de SP-DiOC18(3) du nouvel endothélium ont été étudiés. Résultats : Les cornées greffées avec 2x10e5 CEC et les contrôles désendothélialisés centralement ont réussi le mieux cliniquement. Les contrôles désendothélialisés complètement sont restés opaques. L’histopathologie a révélé une monocouche endothéliale fonctionnelle dans les cornées greffées avec 2x10e5 CEC et les contrôles désendothélialisés centralement, une multicouche endothéliale non-fonctionnelle dans les cornées désendothélialisées centralement et greffées avec 1x10e6 CEC, et un endothélium fibrotique non-fonctionnel dans les cornées désendothélialisées complètement. L’expression de SP-DiOC18(3) était rare dans les greffes. Conclusion : La thérapie par injection cellulaire a reconstitué un endothélium partiellement fonctionnel, auquel les CEC injectées n’ont contribué que peu. L’injection de Y-27632 sans CEC a reconstitué l’endothélium le plus sain. Des études additionnelles investiguant l’effet thérapeutique de Y-27632 seul sont justifiées.
Resumo:
BACKGROUND Elephants are classified as critically endangered animals by the International Union for Conservation of Species (IUCN). Elephant endotheliotropic herpesvirus (EEHV) poses a large threat to breeding programs of captive Asian elephants by causing fatal haemorrhagic disease. EEHV infection is detected by PCR in samples from both clinically ill and asymptomatic elephants with an active infection, whereas latent carriers can be distinguished exclusively via serological assays. To date, identification of latent carriers has been challenging, since there are no serological assays capable of detecting seropositive elephants. RESULTS Here we describe a novel ELISA that specifically detects EEHV antibodies circulating in Asian elephant plasma/serum. Approximately 80 % of PCR positive elephants display EEHV-specific antibodies. Monitoring three Asian elephant herds from European zoos revealed that the serostatus of elephants within a herd varied from non-detectable to high titers. The antibody titers showed typical herpes-like rise-and-fall patterns in time which occur in all seropositive animals in the herd more or less simultaneously. CONCLUSIONS This study shows that the developed ELISA is suitable to detect antibodies specific to EEHV. It allows study of EEHV seroprevalence in Asian elephants. Results confirm that EEHV prevalence among Asian elephants (whether captive-born or wild-caught) is high.
Resumo:
A bottlenose dolphin, stranded in the Canary Islands in 2001 exhibited non-suppurative encephalitis. No molecular detection of cetacean morbillivirus (CeMV) was found, but a herpesviral-specific band of 250 bp was detected in the lung and brain. The sequenced herpesviral PCR product was compared with GenBank sequences, obtaining 98% homology (p-distance of 0.02) with Human herpesvirus 1 (herpes simplex virus 1 or HSV-1). This is the first report of a herpes simplex-like infection in a stranded dolphin.
Resumo:
Le rôle de l'inflammation dans le développement et la progression des maladies rénales chroniques (MRC) chez le chat a été peu étudié. L'hepcidine est une protéine de la phase aigue (PPA) de l'inflammation qui contribue au développement des anémies lors de MRC chez l'homme. Les objectifs de cette étude sont de comparer les concentrations en PPAs, en erythropoietine (EPO) ainsi que le statut en fer entre un groupe de chats sains et en MRC. 18 chats sains et 38 chats en MRC ont été recrutés de façon prospective. Les examens réalisés incluaient hématologie, biochimie, analyse d'urine, Serum amyloid A (SAA), haptoglobine (HAP), EPO, hepcidine,fer, TIBC et ferritinne. Nous avons observé une augmentation significative des concentrations en SAA et en hepcidine ainsi qu'une diminution significative du fer et du TIBC dans le groupe MRC (P < .05). Une corrélation positive entre la créatinine et certaines PPAs (SAA and hepcidin; P < .05) était présente. L'augmentation de SAA et hepcidine était significativement associé avec une diminution du TIBC et de l'hématocrite dans le groupe MRC. Les 14 (37%) chats anémiques du groupe MRC avaient une concentration significativement plus basse en fer et en TIBC (P < .05), changements compatibles avec une déficience fonctionelle en fer. Aucun chat n'avait un panel de fer compatible avec une carence en fer absolue. En conclusion, les résultats de cette étude suggèrent que les MRC chez le chat sont des conditions pro-inflammatoires, ayant un impact sur le métabolisme du fer.
Resumo:
Introduction : Malgré leur état non-prolifératif in vivo, les cellules endothéliales cornéennes (CEC) peuvent être amplifiées in vitro. Leur transplantation subséquente par injection intracamérale pourrait surmonter la pénurie de tissus associée à l’allo-greffe traditionnelle – l’unique traitement définitif disponible pour les endothéliopathies cornéennes. Objectif : Évaluer la fonctionnalité d’un endothélium cornéen reconstitué par injection de CEC dans la chambre antérieure du félin. Méthodes : Les yeux droits de 16 animaux ont été opérés. Huit ont été désendothélialisés centralement avec injection de 2x10e5 (n=4) ou 1x10e6 (n=4) CEC félines supplémentées avec Y-27632 et marquées avec SP-DiOC18(3). Deux ont été désendothélialisés complètement et injectés avec 1x10e6 CEC et Y-27632. Six contrôles ont été désendothélialisés centralement (n=3) ou complètement (n=3) et injectés avec Y-27632 sans CEC. La performance clinique, l’intégrité anatomique, le phénotype fonctionnel et l’expression de SP-DiOC18(3) du nouvel endothélium ont été étudiés. Résultats : Les cornées greffées avec 2x10e5 CEC et les contrôles désendothélialisés centralement ont réussi le mieux cliniquement. Les contrôles désendothélialisés complètement sont restés opaques. L’histopathologie a révélé une monocouche endothéliale fonctionnelle dans les cornées greffées avec 2x10e5 CEC et les contrôles désendothélialisés centralement, une multicouche endothéliale non-fonctionnelle dans les cornées désendothélialisées centralement et greffées avec 1x10e6 CEC, et un endothélium fibrotique non-fonctionnel dans les cornées désendothélialisées complètement. L’expression de SP-DiOC18(3) était rare dans les greffes. Conclusion : La thérapie par injection cellulaire a reconstitué un endothélium partiellement fonctionnel, auquel les CEC injectées n’ont contribué que peu. L’injection de Y-27632 sans CEC a reconstitué l’endothélium le plus sain. Des études additionnelles investiguant l’effet thérapeutique de Y-27632 seul sont justifiées.
Resumo:
Malignant Catarrhal Fever (MCF), an often-lethal infectious disease, presents as a variable complex of lesions in susceptible ungulate species. The disease is caused by a -herpesvirus following transmission from an inapparent carrier host. Two major epidemiological forms exist: wildebeest-associated MCF (WA-MCF), in which the virus is transmitted to susceptible species by wildebeest calves less than approximately four months of age, and sheepassociated MCF (SA-MCF) in which the virus is spread by sheep (primarily adolescents). Due to the lack of an in-vitro propagation system for the causative agent of the more economically significant SA-MCF, and with the expectation that cross-protective immunity may be provided, vaccine development has focused on the more easily propagated alcelaphine herpesvirus-1 (AlHV-1) that causes WA-MCF. In 2008 a direct viral challenge trial showed that a novel vaccine, employing an attenuated AlHV-1 (atAlHV-1) `C5000 virus strain, protected British Friesian-Holstein (FH) cattle against an intranasal challenge with virulent AlHV-1 `C5000 virus. For cattle keeping people living near wildebeest calving areas in sub-Saharan Africa an effective vaccine would have value as it would release them from the costly annual disease avoidance strategy of having to move their herds away from the oncoming wildebeest. On the other hand, an effective vaccine will release herd owners from the need to avoid MCF, allowing them to graze their cattle alongside wildebeest on the highly nutritious pastures of the calving areas. As such conservationists have raised concerns that the development of a vaccine might lead to detrimental grazing competition. The principle objective of this study was to test the novel vaccine on Tanzanian shorthorn zebu cross cattle (SZC).We did this firstly using a natural challenge field trial (Chapter Two) which demonstrated that immunisation with the atAlHV-1 vaccine was well tolerated and induced an oro-nasopharyngeal AlHV-1-specific and -neutralising antibody response. This resulted in an immunity in SZC cattle that was partially protective and reduced naturally transmitted infection by 56%. We also demonstrated that non-fatal infections occurred with a much higher frequency than previously thought. Because the calculated efficacy of the vaccine was less than that seen in British FH cattle we wanted to determine whether host factors, particular to SZC cattle, had impacted the outcomes of the field trial. To do this we repeated the 2008 direct viral challenge trial using SZC cattle (Chapter Four). During this trial we also investigated whether the recombinant bacterial flagellin monomer (FliC), when used as an adjuvant, might improve the vaccine’s efficacy. The findings from this trial indicated that direct challenge with pathogenic AlHV-1 is effective at inducing MCF in SZC cattle and that FliC is not an appropriate adjuvant for this vaccine. Furthermore, with less control group cattle dying of MCF than expected we speculate that SZC cattle may have a degree of resistance to MCF that affords them protection from infection and developing fatal disease. In Chapter Three we investigated aspects of the epidemiology of MCF, specifically whether wildebeest placenta, long implicated by Maasai cattle owners as a source of MCF, might play a role in viral transmission. Additionally, through comparative sequence analysis, at two specific genes (A9.5 and ORF50) of wild-type and atAlHV-1, we investigated whether the `C5000 strain, the source of which was taken from Africa more than 40 years ago, was appropriate for vaccine development. The detection of AlHV-1 virus in approximately 50% of placentae indicated that infection can occur in-utero and that this tissue might play a role in disease transmission. And, despite describing three new alleles of the A9.5 gene (supporting previous evidence that this gene is polymorphic and encodes a secretory protein with interleukin-4 as the major homologue), the observation that the most frequently detected haplotypes, in both wild-type and attenuated AlHV-1, were identical suggests that AlHV-1 has a slow molecular clock and that the attenuated strain was appropriate for vaccine development. In Chapter Five we present the first quantitative assessment of the annual MCF avoidance costs that Maasai pastoralists incur. In particular we estimated that as a result of MCF avoidance 64% of the total daily milk yield during the MCF season was not available to be used by the 81% of the family unit remaining at the permanent boma. This represents an upper-bound loss of approximately 8% of a household0s annual income. Despite these considerable losses we concluded that, given an incidence of fatal MCF in cattle living in wildebeest calving areas of 5% to 10%, if herd owners were to stop trying to avoid MCF by allowing their cattle to graze alongside wildebeest, any gains made through increased availability of milk, improved body condition and reduced energy demands would be offset by an increase in MCF-incidence. With the development of an effective vaccine, however, this alternative strategy might become optimal. The overall conclusion we draw therefore is that, despite the substantial costs incurred each year avoiding MCF, the partial protection afforded by the novel vaccine strategy is not sufficient to warrant a wholesale change in disease avoidance strategy. Nonetheless, even the partial protection provided by this vaccine could be of value to protect animals that cannot be moved, for example where some of the herd remain at the boma to provide milk or where land-use changes make traditional disease avoidance difficult. Furthermore, the vaccine may offer a feasible solution to some of the current land-use challenges and conflicts, providing a degree of protection to valuable livestock where avoidance strategies are not possible, but with less risk of precipitating the potentially damaging environmental consequences, such as overgrazing of highly nutritious seasonal pastures, that might result if herd owners decide they no longer need to avoid wildebeest.
Resumo:
Este relatório foi elaborado na sequencia do estágio curricular realizado pelo autor, ente 28 de setembro de 2015 e 28 de março de 2016, no Hospital Clínico Veterinario de la Universidad CEU Cardenal Herrera (HCV CEU-UCH), em Alfara del Patriarca, Valência, Espanha. A infeciologia foi a área da clínica médica mais representativa (28%), sendo o vírus da imunodeficiência felina (FIV) o agente infecioso registado mais frequentemente (19%). É importante reconhecer e diagnosticar esta infeção de forma a aplicar um maneio adequado aos pacientes infetados, melhorando a sua qualidade de vida e prevenindo a propagação do vírus. A infeção provocada pelo FIV raramente provoca uma síndrome severa, porém, várias alterações podem decorrer. Apesar do FIV provocar uma infeção crónica, com os cuidados adequados, os pacientes infetados poderão viver vidas longas, com uma boa qualidade de vida, e eventualmente acabar por morrer de causas não relacionadas com o FIV; Abstract: Small Animal Medicine and Surgery This report was elaborated following the externship performed by the author, between September 28th 2015 and March 28th 2016, at the Hospital Clínico Veterinario de la Universidad CEU Cardenal Herrera (HCV CEU-UCH), in Alfara del Patriarca, Valencia, Spain. The most frequent specialty field within the area of internal medicine was infectiology (28%), with feline immunodeficiency virus (FIV) being the infectious agent most frequently registered (19%). It is important to recognize and diagnose the infection caused by this agent accurately, so that the right measures of management can be applied, improving the life’s quality of the patient and reducing the risk of viral spreading. The infection by FIV rarely produces a severe syndrome, however many clinicopathologic disorders may occur. FIV causes a chronic infection, however, with the proper care, the infected cats may live long lives, with a fair quality, eventually ending up dying from causes unrelated to FIV.
Resumo:
Este relatório foi elaborado no âmbito do estágio curricular do Mestrado Integrado em Medicina Veterinária. Encontra-se dividido em duas partes. Na primeira parte é feita uma análise da casuística seguida durante o estágio. A segunda parte é constituída por uma monografia de revisão bibliográfica sobre o tema ”Tromboembolismo Arterial Felino”(TAF), bem como a descrição e discussão de dois casos clínicos acompanhados durante o estágio. O TAF é caracterizado pela embolização de um trombo numa artéria da circulação sistémica, sendo a localização mais frequente a trifurcação ilíaca da artéria aorta. Na maioria dos casos, o trombo tem origem no átrio esquerdo, como resultado de cardiomiopatia. Apesar do diagnóstico ser facilmente obtido através de sinais clínicos, o tratamento e a prevenção desta afeção representam um desafio para o médico veterinário, já que a taxa de reincidência de tromboembolismo e mortalidade são elevadas, projectando um prognóstico reservado; Clinic and Surgery of Small Animals Abstract: This report was done within the scope of the internship integrated master’s degree in Veterinay Medicine. It is divided in two parts. In the first part, an analisys of the casuistic followed during the internship is done. The second part is composed by a literature review about the theme ”Feline Arterial Thromboembolism”(FAT), as well as the description and discussion of two clinical cases followed during the internship. FAT is characterized by the embolization of a thrombus in a artery of systemic circulation, being its location more frequently in iliac trifurcation of aorta artery. On most of the cases the thrombus has its origins on the left atrium, as a result of cardiomyopathy. Besides the diagnosis being easily obtained through clinical signs, the treatment and prevention of this disease represents a challenge to the veterinarian clinician, due to the FAT recurrance rate and high mortality, projecting a pour/reserved prognosis.
Resumo:
O presente relatório diz respeito ao estágio curricular realizado no Hospital Veterinário de Portimão, sob a orientação da Prof. Doutora Josefina Coucelo e com a duração de cinco meses, entre um de janeiro de 2016 e trinta e um de maio de 2016. Este relatório foi realizado no âmbito da conclusão do Mestrado Integrado em Medicina Veterinária e consiste em duas partes. A primeira é referente aos casos acompanhados no decorrer do estágio curricular, e a segunda é uma revisão bibliográfica do tema “Leishmaniose Felina”, seguida de um caso clínico acompanhado pelo autor. A Leishmaniose é uma importante zoonose, endémica em várias regiões no mundo, como o sul da Europa, afetando variados mamíferos, debilitando-os e podendo ser fatal. Causada por protozoários do género Leishmania, considera-se como uma afeção rara em gatos. Existe um número crescente de casos nesta espécie, que não é, no entanto, reservatório da infeção para humanos; Small Animal Practice Abstract: The present report describes a training in Portimãos’s Veterinary Hospital, under Doctor Josefina Coucelo’s supervision with the duration of five months, between the 1st January 2016 and the 31st May 2016. This report was written in the context of the Veterinary Medicine Integrated Master degree’s conclusion and is made up of two parts. The first refers to the clinical cases followed during the training and the second is a monography about “Feline Leishmaniasis”, followed by a case report on the subject observed by the author. Leishmaniasis is an important zoonosis endemic in many world regions as well as in southern Europe, affecting many mammals debilitating them and sometimes fatal. It is caused by protozoan of the genus Leishmania. It’s considered a rare affection in cats, however, there’s an increasing number of cases in this host species which still isn’t considered a human infection reservoir.
Resumo:
estágio curricular foi realizado no Hospital Veterinário das Laranjeiras, em Lisboa, de Outubro de 2014 a Abril de 2015, sob a orientação científica do Dr. Luís Cruz. O relatório aqui apresentado divide-se em três partes. A primeira parte consiste na descrição da casuística assistida, com uma breve descrição dos procedimentos sempre que se tornar relevante. Na segunda parte desenvolveu-se o tema “Pancreatite Felina” com um enquadramento teórico sobre a fisiologia do pâncreas exócrino. Desenvolveu-se, de seguida, uma revisão bibliográfica sobre a fisiopatologia da doença em felinos, a apresentação clínica, as complicações, o diagnóstico, o tratamento, o acompanhamento dos pacientes e o prognóstico. A última parte consiste num estudo retrospetivo de Pancreatite Felina em 24 casos clínicos, alguns dos quais foram acompanhados durante o estágio; Abstract: Feline Pancreatitis - a retrospective study of 24 feline clinical cases The internship was conducted at the Hospital Veterinário das Laranjeiras, in Lisbon, from October 2014 to April 2015, under the scientific supervision of Dr. Luís Cruz. This report is divided in three parts. The first part consists of a statistical analysis of the cases observed during the internship, with a small description of the procedures whenever it is relevant. The second part is the development of the theme “Feline Pancreatitis” with a theoretical framework about physiology of the exocrine pancreas. Afterward there is a review of the physiopathology of the disease in cats, clinical presentation, complications, diagnosis, treatment, follow-ups, and prognosis. The last part consists of a retrospective study of Feline Pancreatitis in 24 clinical cases, some of which were followed during the internship.
Resumo:
L’ipertiroidismo felino rappresenta oggi la più comune endocrinopatia della specie. I capitoli 2 e 3 costituiscono una revisione della letteratura in merito agli aspetti clinici, diagnostici e terapeutici della patologia. Il capitolo 4 indaga il ruolo della dimetilarginina simmetrica (SDMA) come marker di funzionalità renale nei gatti ipertiroidei prima e dopo terapia medica. La patologia tiroidea più comune nel cane è l’ipotiroidismo. Nello studio riportato al capitolo 5 sono state indagate le performance diagnostiche di freeT3, freeT4, rT3, 3,3-T2 e 3,5-T2, misurati tramite LC-MS/MS, nel differenziare tra cani ipotiroidei, cani con patologie non-tiroidee e cani sani. La presenza di una possibile correlazione tra la gravità della condizione clinica dei pazienti ipotiroidei, le variabili emato-chimiche e le concentrazioni sieriche di cTSH è stata valutata nel capitolo 6. Il capitolo 7 valuta l’andamento dell’SDMA in cani ipotiroidei prima e dopo supplementazione ormonale. A differenza della Sindrome di Cushing dell’uomo, che è considerata una malattia rara, nel cane l’ipercortisolismo spontaneo (HC) è una delle endocrinopatie più comuni. Gli aspetti epidemiologici dell’HC e la ricerca di un metodo di monitoraggio alternativo al test di stimolazione con ACTH nei cani trattati con Trilostano sono stati approfonditi rispettivamente nei capitoli 8 e 9. A differenza dell'HC, l'ipoadrenocorticismo primario (PH) è una patologia rara nel cane. Lo scopo dello studio riportato nel capitolo 10 consiste nel descrivere le frazioni escretorie degli elettroliti urinari nei cani con PH e di indagare se esse possano rappresentare un utile supporto alla diagnosi e al trattamento del PH canino. Il riscontro accidentale di masse surrenaliche rappresenta una criticità diagnostica. Infatti, può essere difficile distinguere morfologicamente tra lesioni corticali e midollari e tra lesioni maligne e benigne. Nel capitolo 11 vengono descritti i rilievi immunoistochimici dell'incidentaloma surrenalico nel cane e viene valutato il ruolo del Ki-67 PI come indicatore di malignità.
Resumo:
Il carcinoma squamocellulare è il tumore maligno orale più frequente nel gatto e si caratterizza per diagnosi spesso tardiva e prognosi infausta. Il progetto riguarda la ricerca di marker di rilevanza dia-gnostica nel carcinoma squamocellulare orale felino (FOSCC), al fine di sviluppare un test di scree-ning non invasivo. È stata condotta un’analisi retrospettiva delle disregolazioni del gene oncosoppres-sore TP53 in campioni istologici di FOSCC e di una popolazione di controllo (lesioni infiammatorie croniche orali e mucose orali normali feline). Tramite next-generation sequencing (NGS) sono state rilevate mutazioni di TP53 nel 69% dei FOSCC, ed anche l’espressione immunoistochimica della pro-teina p53 era presente nel 69% dei tumori, con una concordanza discreta (77%) fra le due alterazioni. Nella popolazione di controllo erano presenti disregolazioni di p53 solo in due lesioni infiammatorie (3%). Successivamente è stata effettuata un’analisi prospettica con NGS della metilazione del DNA di 17 geni, noti per essere disregolati nel carcinoma squamocellulare orale umano o felino, insieme all’analisi mutazionale di TP53, in campioni istologici di FOSCC e in un gruppo di controllo. Le stesse indagini molecolari sono state svolte in parallelo su campioni di cellule prelevate mediante brushing orale. Utilizzando 6 dei geni indagati differenzialmente metilati nei FOSCC (FLI1, MiR124-1, KIF1A, MAGEC2, ZAP70, MiR363) e lo stato mutazionale diTP53, è stato impostato un algoritmo diagnostico per differenziare i FOSCC dalla mucosa orale non neoplastica. Applicato ai brushing, l’algoritmo è risultato positivo (indicativo di carcinoma) in 24/35 (69%) gatti con FOSCC, contro 2/60 (3%) controlli (sensibilità: 69%; specifici-tà: 97%). La quota di FOSCC identificati era significativamente maggiore nei gatti sottoposti a prelievo in anestesia generale rispetto ai gatti svegli. Questi risultati sono incoraggianti per il riconoscimento precoce del FOSCC tramite brushing orale. Saranno necessari ulteriori studi su casistiche più ampie per validare questa metodica e migliorarne la sensibilità.